CDAK Insider Trading Activity and SEC Form 4 Filings
CDAK insider trading summary
No open-market insider purchases or sales of Codiak BioSciences, Inc. (CDAK) have been reported on SEC Form 4 in the past 12 months.
Latest CDAK insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Mar 30, 2023 | Yalonda Howze | See Remarks | Sell | $318 (1,628 @ $0.20) |
| Mar 29, 2023 | Sriram Sathyanarayanan | Chief Scientific Officer | Sell | $2K (11,762 @ $0.17) |
| Mar 29, 2023 | Nicole Barna | See Remarks | Sell | $321 (1,932 @ $0.17) |
| Mar 29, 2023 | Nicole Barna | See Remarks | Sell | $887 (5,373 @ $0.17) |
| Mar 28, 2023 | Douglas E Williams | President & CEO | Sell | $8K (41,667 @ $0.18) |
| Mar 28, 2023 | Konstantin Konstantinov | Chief Technology Officer | Sell | $386 (1,932 @ $0.20) |
| Mar 28, 2023 | Konstantin Konstantinov | Chief Technology Officer | Sell | $1K (7,432 @ $0.20) |
| Mar 28, 2023 | Linda Bain | Chief Financial Officer | Sell | $2K (13,412 @ $0.17) |
| Feb 17, 2023 | Douglas E Williams | President & CEO | Sell | $5K (7,681 @ $0.59) |
| Feb 17, 2023 | Linda Bain | Chief Financial Officer | Sell | $2K (2,570 @ $0.59) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.